Identification of immunogenic LY6K long peptide encompassing both CD4<sup>+</sup>and CD8<sup>+</sup>T-cell epitopes and eliciting CD4<sup>+</sup>T-cell immunity in patients with malignant disease

Yusuke Tomita(Kumamoto University Hospital), Yasuharu Nishimura(Kumamoto University), Mohammad Sayem(Mawlana Bhashani Science and Technology University), Akira Yuno(National Institutes of Health), Masanori Shinohara(Kumamoto University), Hirotake Tsukamoto(Kumamoto University), Junji Yatsuda(Kumamoto University), Akinobu Hamada(National Cancer Research Institute), Hirofumi Jono(Kumamoto City Hospital), Hirotsugu Kohrogi(Respiratory Clinical Trials), Satoru Senju(Kumamoto University), Yasuhiro Kuroda(Kagawa University), Yusuke Nakamura(National Institute of Biomedical Innovation, Health and Nutrition), Yoshihiro Yoshitake(Kumamoto University), Koji Yoshida(Tokyo University of Science), Masatoshi Hirayama(Kumamoto University), Atsushi Irie(Kumamoto University), Takuya Tsunoda(Tokyo University of Science), Yuya Imamura(Kumamoto University), Yataro Daigo(The University of Tokyo)
OncoImmunology
March 1, 2014
Cited by 17


Related Papers